Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Historical Look at the Characterization of Lupus as a Systemic Disease

Ruth Jessen Hickman, MD  |  Issue: October 2018  |  October 18, 2018

nukeaf / shutterstock.com

nukeaf / shutterstock.com

The disease called systemic lupus erythematosus (SLE) went through many different stages of classification before reaching the modern criteria reflecting our current understanding of its pathogenesis. In 1872, the Viennese dermatologist Moriz Kaposi, MD, published a paper, “New Contributions to Knowledge of Lupus Erythematosus,” which provided a significant leap forward in the characterization of this condition.1,2

Born Moriz Kohn, Dr. Kaposi changed his name in 1871 following his conversion to Catholicism, in reference to his birth town Kaposvár, in the Austro-Hungarian Empire. According to JAMA Dermatology, “It is still debated why he changed his surname; it is unlikely to have been due to the pressures of anti-Semitism because Kaposi was not an opportunist, and at that time he was well established in his career. According to his own words, he changed his surname to avoid confusion with five other physicians named similarly in the Vienna School of Medicine.”3,4

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Kaposi’s careful case studies in the 1872 paper provided key descriptions of SLE that remain relevant to this day. Moreover, his work serves as a reminder of the way we still strive to lump and split disease states, hoping to improve classification (and ultimately treatment) of rheumatic diseases.

Early Characterizations

The characterization of lupus goes back more than two millennia. As early as 400 B.C., the Greek physician Hippocrates described what is thought to be the first documented case of lupus.5 During the Middle Ages, the term lupus (from the Latin for wolf) was used to designate a broad category of ulcerative skin diseases. Viewed from a medieval viewpoint as evil sores and ill-favored lesions, the designation probably was applied to lesions of leprosy, tuberculosis, syphilis and skin cancer, as well as lupus erythematosus itself.6,7

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

At the beginning of the 19th century, the term lupus was used to describe ulcerative skin diseases that affected the face only.8 Ultimately, lupus vulgaris (the cutaneous form of tuberculosis) was thought to be a separate disease entity.7 The French dermatologist Pierre Louis Alphée Cazenave helped provide the first modern description of what would become SLE, with Cazenave applying the term lupus érythèmateux in 1850.9 This was later Latinized to lupus erythematosus by the Viennese physician Ferdinand von Hebra, who was the first to describe the signature butterfly rash, as well as two different rash patterns associated with lupus erythematosus: those of a disc-like pattern and those of a more confluent nature.2,5

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Classification CriteriaDr. Moriz KaposiHistoryLost & Found

Related Articles

    Rheumatologists, Social Workers Collaborate to Help Patients with Lupus

    April 19, 2017

    At the Hospital for Special Surgery (HSS), New York, rheumatologists and social workers have found that an interdisciplinary approach to care for systemic lupus erythematosus (SLE) patients improves the overall patient experience. “Our goal is to help patients navigate the complex healthcare system,” says Jillian Rose, LCSW, MPH, assistant director, Community Engagement, Diversity & Research….

    Lupus often presents with a butterfly rash.

    Top 12: Research in Systemic Lupus Erythematosus at a Glance

    November 18, 2021

    Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    2019 EULAR/ACR SLE Classification Criteria Offer Improved Sensitivity & Specificity

    November 6, 2019

    The new EULAR/ACR classification criteria for SLE offer improved sensitivity and specificity, as well as more accurately reflect the current tests used to clinically diagnose SLE. A positive ANA test is obligatory…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences